OMIM 210720 | ||
Microcephalic osteodysplastic primordial dwarfism type II (MOPD II) is listed as a "rare disease" by the Office of Rare Diseases (ORD) of the National Institutes of Health (NIH). This means that MOPD, or a subtype of MOPD, affects less than 200,000 people in the US population and a form of dwarfism associated with brain and skeletal abnormalities.
It was characterized in 1982.
It is associated with PCNT.
References
Microcephalic osteodysplastic primordial dwarfism type II Wikipedia(Text) CC BY-SA